Shouyao Holdings (Beijing) Future Growth
Future criteria checks 2/6
Shouyao Holdings (Beijing) is forecast to grow earnings and revenue by 35.4% and 134.1% per annum respectively. EPS is expected to grow by 35.6% per annum. Return on equity is forecast to be -14.7% in 3 years.
Key information
35.4%
Earnings growth rate
35.6%
EPS growth rate
| Pharmaceuticals earnings growth | 19.4% |
| Revenue growth rate | 134.1% |
| Future return on equity | -14.7% |
| Analyst coverage | Low |
| Last updated | 13 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 241 | -65 | -68 | -67 | 1 |
| 12/31/2025 | 46 | -176 | -126 | -125 | 1 |
| 12/31/2024 | 10 | -173 | -98 | -98 | 1 |
| 9/30/2024 | 4 | -209 | -196 | -188 | N/A |
| 6/30/2024 | 4 | -195 | -190 | -186 | N/A |
| 3/31/2024 | 5 | -192 | -185 | -182 | N/A |
| 12/31/2023 | 5 | -186 | -183 | -180 | N/A |
| 9/30/2023 | 5 | -191 | -186 | -178 | N/A |
| 6/30/2023 | 5 | -183 | -179 | -169 | N/A |
| 3/31/2023 | 2 | -170 | -159 | -140 | N/A |
| 12/31/2022 | 2 | -174 | -150 | -129 | N/A |
| 9/30/2022 | 4 | -160 | -124 | -105 | N/A |
| 6/30/2022 | 8 | -159 | -106 | -88 | N/A |
| 3/31/2022 | 9 | -161 | -108 | -99 | N/A |
| 12/31/2021 | 13 | -145 | -111 | -104 | N/A |
| 9/30/2021 | 11 | -134 | -91 | -112 | N/A |
| 3/31/2021 | 4 | -349 | -116 | -112 | N/A |
| 12/31/2020 | 7 | -330 | -97 | -93 | N/A |
| 12/31/2019 | 12 | -40 | -86 | -85 | N/A |
| 12/31/2018 | 20 | -12 | 18 | 19 | N/A |
| 12/31/2017 | 31 | -4 | N/A | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688197 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 688197 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 688197 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 688197's revenue (134.1% per year) is forecast to grow faster than the CN market (14% per year).
High Growth Revenue: 688197's revenue (134.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688197 is forecast to be unprofitable in 3 years.